{Reference Type}: Journal Article
{Title}: Exploring the role of microRNAs as diagnostic and prognostic biomarkers in canine mammary tumors.
{Author}: Ferreira T;da Costa RMG;Dias F;Gama A;Gaspar VM;Mano JF;Oliveira PA;Medeiros R;
{Journal}: Geroscience
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 2
{Factor}: 7.581
{DOI}: 10.1007/s11357-024-01260-7
{Abstract}: Canine mammary tumors (CMTs) represent a significant health concern in dogs, with a high incidence among intact female dogs. CMTs are a promising comparative model for human breast cancer, due to sharing several pathophysiological features. Additionally, CMTs have a strong genetic correlation with their human counterpart, including the expression of microRNAs (miRNAs). MiRNAs are a class of non-coding RNAs that play important roles in post-translational regulation of gene expression, being implicated in carcinogenesis, tumor progression, and metastasis. Moreover, miRNAs hold promise as diagnostic, prognostic, and metastatic biomarkers. Understanding the molecular mechanisms underlying CMTs is crucial for improving diagnosis, prognosis, and monitoring of treatments. Herein, we provide a comprehensive overview of the current knowledge on miRNAs in CMTs, highlighting their roles in carcinogenesis and their potential as biomarkers. Additionally, we highlight the current limitations and critically discuss the overarching challenges in this field, emphasizing the need for future research to translate miRNA findings into veterinary clinical practice.